Search hospitals > Georgia > Marietta
Northwest Georgia Oncology Centers, P.C.
Claim this profileMarietta, Georgia 30060
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Parkinson's disease
Conducts research for Renal Cell Carcinoma
Conducts research for Pancreatic Cancer
122 reported clinical trials
2 medical researchers
Summary
Northwest Georgia Oncology Centers, P.C. is a medical facility located in Marietta, Georgia. This center is recognized for care of Breast Cancer, Lung Cancer, Parkinson's disease, Renal Cell Carcinoma, Pancreatic Cancer and other specialties. Northwest Georgia Oncology Centers, P.C. is involved with conducting 122 clinical trials across 72 conditions. There are 2 research doctors associated with this hospital, such as Steven L McCune and Steve McCune.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Steven L McCuneNorthwest Georgia Oncology Center, P.C.8 years of reported clinical research
Studies Prostate Cancer
Studies Chronic Illness
4 reported clinical trials
10 drugs studied
Steve McCuneNorthwest Georgia Oncology Centers, P.C.3 years of reported clinical research
Studies Bladder Cancer
Studies Transitional Cell Carcinoma
1 reported clinical trial
2 drugs studied
Clinical Trials running at Northwest Georgia Oncology Centers, P.C.
Lung Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Small Cell Lung Cancer
Lymphoma
Pancreatic Cancer
Mantle Cell Lymphoma
Non-Small Cell Lung Cancer
B-Cell Leukemia
Pembrolizumab + Sacituzumab Tirumotecan
for Lung Cancer
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS).
Recruiting2 awards Phase 32 criteria
MK-2870
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate sacituzumab tirumotecan versus chemotherapy (docetaxel or pemetrexed) for the treatment of previously-treated non-small cell lung cancer (NSCLC) with exon 19del or exon 21 L858R EGFR mutations (hereafter referred to as EGFR mutations or EGFR-mutated) or any of the follow genomic alterations: ALK gene rearrangements, ROS1 rearrangements, BRAF V600E mutations, NTRK gene fusions, MET exon 14 skipping mutations, RET rearrangements, or less common EGFR point mutations of exon 20 S768I, exon 21 L861Q, or exon 18 G719X mutations. The primary hypotheses are that sacituzumab tirumotecan is: (1) superior to chemotherapy with respect to progression-free survival (PFS) per RECIST 1.1 as assessed by BICR in NSCLC with EGFR mutations; and (2) superior to chemotherapy with respect to overall survival (OS) in NSCLC with EGFR mutations.
Recruiting2 awards Phase 39 criteria
Sacituzumab Tirumotecan vs Standard Therapy
for Lung Cancer
The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squamous non-small cell lung cancer (NSCLC). Participants in this study have NSCLC that has continued to progress on prior treatment with EGFR tyrosine kinase inhibitors (TKIs). The primary hypotheses of this study are that sacituzumab tirumotecan is better than platinum-based doublet chemotherapy (pemetrexed and carboplatin) in regard to progression-free survival (PFS) and overall survival (OS).
Recruiting2 awards Phase 32 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northwest Georgia Oncology Centers, P.C.?
Northwest Georgia Oncology Centers, P.C. is a medical facility located in Marietta, Georgia. This center is recognized for care of Breast Cancer, Lung Cancer, Parkinson's disease, Renal Cell Carcinoma, Pancreatic Cancer and other specialties. Northwest Georgia Oncology Centers, P.C. is involved with conducting 122 clinical trials across 72 conditions. There are 2 research doctors associated with this hospital, such as Steven L McCune and Steve McCune.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.